DOSSIER · UPDATED 18 NOV 2025

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on…

eikontx.com ↗Claim this profile
Founded
2019
Headcount
271
Open roles
21
Last raised
Series D · $351M
SECTION I · THE BRIEF

Inside Eikon Therapeutics

Brief #87236Updated 18 NOV 2025HAYWARDMEDICAL ORGANIZATIONSSERIES D
Employbl Dossier

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery…

Founded
2019
Headcount
271
Open roles
21
Last raised
Series D · $351M
Section II · Premium ProfileMembers only
  • 01Engineering interview process at Eikon TherapeuticsLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked
Open Eikon Therapeutics briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Xavier Darzacq

Xavier Darzacq

Founder at Eikon Therapeutics

UC BerkeleyCNRSAlbert Einstein College of MedicineEikon TherapeuticsEcole Normale SupérieureUniversité Paul Sabatier Toulouse III

Luke Lavi

Founder at Eikon Therapeutics

Eikon Therapeutics
OPEN ROLES

Hiring at Eikon Therapeutics

FUNDING

Capital raised

Total Amount Raised: $1,122,700,032

Eikon Therapeutics' Investors

Eikon Therapeutics Funding Rounds

  • Series D

    $350,700,000

  • Series D

    $350,700,000

    Series D Investors

    Foresite Capital
    Alexandria Venture Investments
    UC Investments
    T. Rowe Price
    StepStone Group
    Lux Capital
    General Catalyst
    The Column Group
    Soros Capital Management
    E15 VC
    AME Cloud Ventures

  • Series C

    $106,000,000

  • Series C

    $106,000,000

  • Series B

    $518,000,000

  • Series B

    $518,000,000

    Series B Investors

    UC Investments
    T. Rowe Price
    EcoR1 Capital
    Canada Pension Plan Investment Board (CPPIB)
    Schroders Capital
    Hartford Healthcare Endowment
    Harel Insurance Investments & Financial Services
    StepStone Group
    ADIA (Abu Dhabi Investment Authority)
    Soros Capital Management
    AME Cloud Ventures
    General Catalyst
    E15 VC
    The Column Group
    Innovation Endeavors
    Lux Capital
    Foresite Capital
    Horizons Ventures

  • Series A

    $148,000,000

  • Series A

    $148,000,000

    Series A Investors

    The Column Group
    Lux Capital
    Innovation Endeavors
    Foresite Capital
    WPSS.bio
    TCG Crossover Management
Funding info provided by Diffbot.
TAGS

Categorized in

Company Collections

These are collections Eikon Therapeutics is a part of. Click on the collection name to view similar companies.

Eikon Therapeutics' Industries

Eikon Therapeutics' Tech Stack

Eikon Therapeutics' Investors

LOCATIONS

Where they work

Eikon Therapeutics Headquarters Location

3929 Point Eden Way, Hayward, CA, 94545

Loading map…